St. Francis, Brooklyn, to drop NCAA D-I athletics program
Judge Delays Next Week's Execution of Texas Death Row Inmate
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in...
Global Biosurfactants Market Report 2022: Sector to Reach $8 Billion by 2028...
Edenbrook Capital Now Owns 14.36% of Brightcove (BCOV)
Judge Delays Next Week's Execution of Texas Death Row Inmate
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in...
Global Biosurfactants Market Report 2022: Sector to Reach $8 Billion by 2028...
Edenbrook Capital Now Owns 14.36% of Brightcove (BCOV)
Targeted Treatments
EconomyPress Release2023-03-20 13:30:00
Acne Treatment Market Trends and Insights by Acne Type (Moderate, Mild, Moderate to Severe), Treatment (Medication, Therapeutic Devices), Drug Type (OTC,...
HealthPress Release2023-03-20 20:05:00
HAMILTON, ON and BOSTON, March 20, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing...
HealthPress Release2023-03-20 15:00:00
DUBLIN, March 20, 2023 /PRNewswire/ -- The "Stem Cell Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This...
SciencePress Release2023-03-20 12:28:00
TORONTO, March 20, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (Revive or the Company) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life...
HealthPress Release2023-03-20 15:20:38
Cancer Therapeutics Market 1 PORTLAND, OR, UNITED STATE, March 20, 2023 / EINPresswire.com / -- Cancer Therapeutics Market - Global Outlook and Forecast...
PoliticsBy Health Day2023-03-20 11:34:00
By Ernie Mundell HealthDay Reporter Bile duct cancers: Funding, research needed to fight this silent killer. As too many American families have discovered,...
HealthPress Release2023-03-20 12:00:00
CAMBRIDGE, Mass., March 20, 2023 /PRNewswire/ -- Convergent Therapeutics Inc., a clinical-stage biotechnology company, today announced the title of an...
HealthPress Release2023-03-20 10:00:00
Company anticipates that the c ombination of pan-TKI dovitinib and PARP inhibitor stenoparib may generate synergistic anti-cancer activity Program initiation...
SciencePress Release2023-03-20 12:00:00
- Treatment with TMB-001 demonstrated greater proportions of participants achieving primary and key secondary endpoints versus vehicle regardless of the...
SciencePress Release2023-03-20 12:00:00
Panel discussion to be held on Saturday, March 25 at 12:00pm ET / 11:00am CT / 9:00am PT. SAN DIEGO, March 20, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc....
HealthPress Release2023-03-20 17:31:00
SAN DIEGO, March 20, 2023 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in...
EconomyPress Release2023-03-20 17:00:00
DUBLIN, March 20, 2023 /PRNewswire/ -- The "Global Seed Treatment Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type, By...
HealthPress Release2023-03-20 11:08:18
Plasma Therapy Market Forecast SEATTLE, WASHINGTON, UNITED STATES, March 20, 2023 / EINPresswire.com / -- Edition: 2023
HealthPress Release2023-03-20 12:40:00
Dr. Raphael Kellman Gives Hope to Patients; Emphasizes Value of Innovative Therapies During Autoimmune Awareness Month NEW YORK, March 20, 2023 /PRNewswire/...
Business / FinanceBy Business Wire2023-03-20 11:06:00
Cure Rare Disease (CRD) - a nonprofit biotechnology company focused on developing treatments for ultra-rare diseases - announces the appointment of leading...
PoliticsBy Health Day2023-03-20 11:47:00
By Dennis Thompson HealthDay Reporter MONDAY, March 20, 2023 (HealthDay News) -- Patients could soon have access to a new injectable drug to treat atopic...
HealthBy Vandana Singh2023-03-20 11:27:42
Novartis AG NVS has presented new data on Zolgensma (onasemnogene abeparvovec), a one-time gene therapy for the treatment of spinal muscular atrophy (SMA)....
Business / FinanceBy Business Wire2023-03-20 11:55:00
Researchers can now access over 8,000 patient-derived xenografts (PDX), cell-derived xenografts (CDX), organoids and cell lines from Scientist.com's...
Business / FinanceBy Business Wire2023-03-20 12:05:00
-- 17 patients were enrolled at the highest dose and no dose limiting toxicities (DLTs) were observed -- RYZ101 positioned to be the first approved...
SciencePress Release2023-03-20 11:00:00
- Positive neuroprotective effect of vorolanib, the active drug in EYP-1901, in a widely validated retinal detachment model demonstrates a potential new...